论文部分内容阅读
目的探讨妈富隆对青春期功能失调性子宫出血青春期功血患者血清促卵泡生成素(FSH)、黄体生成素(l LH)、雌激素(E2)水平的影响。方法选取2014年1月至2015年1月青春期功能失调性子宫出血患者87例,依据治疗方案分为妈富隆组44例与米非司酮组43例,比较两组治疗前后血清FSH、LH、E2水平。结果妈富隆组总有效率(97.73%)高于米非司酮组(81.40%),差异有统计学意义(P<0.05)。治疗后妈富隆组患者血清FSH、LH、E2水平低于治疗前及米非司酮组,差异有统计学意义(P<0.05)。结论妈富隆对青春期功能失调性子宫出血患者的临床疗效显著,且显著改善血清FSH、LH、E2水平,值得临床推广应用。
Objective To investigate the effects of Marvelon on serum levels of FSH, LH and E2 in adolescent dysfunctional uterine bleeding patients with adolescent dysfunctional uterine bleeding. Methods 87 patients with adolescent dysfunctional uterine bleeding from January 2014 to January 2015 were divided into 44 cases of Marvelon group and 43 cases of mifepristone group according to the treatment regimen. The levels of serum FSH, LH, E2 level. Results The total effective rate of Marvelon group (97.73%) was higher than that of mifepristone group (81.40%), the difference was statistically significant (P <0.05). The levels of serum FSH, LH and E2 in Marvelon patients after treatment were lower than those before treatment and mifepristone group (P <0.05). Conclusion Marvelon has significant clinical effect on adolescent dysfunctional uterine bleeding and significantly improves serum FSH, LH and E2 levels, which is worthy of clinical application.